|
TMEM133 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89300003345028E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11560000126687E-08 |
| Normal-vs-Stage2 |
2.376300E-04 |
| Normal-vs-Stage3 |
4.401600E-02 |
| Normal-vs-Stage4 |
3.012200E-01 |
| Stage1-vs-Stage2 |
4.239000E-01 |
| Stage1-vs-Stage3 |
1.107610E-01 |
| Stage1-vs-Stage4 |
1.335230E-01 |
| Stage2-vs-Stage3 |
6.786000E-02 |
| Stage2-vs-Stage4 |
5.702400E-02 |
| Stage3-vs-Stage4 |
6.734400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.81300002472562E-09 |
| Normal-vs-AfricanAmerican |
3.89030000003121E-06 |
| Normal-vs-Asian |
3.444400E-01 |
| Caucasian-vs-AfricanAmerican |
8.104800E-01 |
| Caucasian-vs-Asian |
8.925600E-01 |
| AfricanAmerican-vs-Asian |
8.423800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.30420000354903E-08 |
| Normal-vs-Female |
1.80279999995037E-06 |
| Male-vs-Female |
5.878600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.571400E-04 |
| Normal-vs-Extreme_Weight |
1.97179999994468E-06 |
| Normal-vs-Obese |
1.55409999980094E-07 |
| Normal-vs-Extreme_Obese |
4.401100E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.889400E-01 |
| Normal_Weight-vs-Obese |
4.226000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.828000E-01 |
| Extreme_Weight-vs-Obese |
5.339000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.366600E-01 |
| Obese-vs-Extreme_Obese |
6.040600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.055400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.20949941570825E-11 |
| Normal-vs-Age(61-80Yrs) |
6.44180000000105E-05 |
| Normal-vs-Age(81-100Yrs) |
9.157300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.986200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.009220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.982000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.153300E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.261400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.812100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.04369912291259E-11 |
| Normal-VS-Type2 PRCC |
9.578000E-04 |
| Normal-VS-KIRP CIMP |
4.260600E-01 |
| Normal-VS-Unclassified PRCC |
1.955390E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.151770E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.026700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.462200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.308100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.534100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.995800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.29079999999326E-05 |
| Normal-vs-N1 |
8.729600E-02 |
| Normal-vs-N2 |
4.400200E-01 |
| N0-vs-N1 |
2.223000E-01 |
| N0-vs-N2 |
3.221000E-01 |
| N1-vs-N2 |
7.644800E-01 |
|
|
